Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vincent Medical Holdings Limited ( (HK:1612) ) has issued an announcement.
Vincent Medical Holdings Limited has issued a positive profit alert, indicating that unaudited consolidated profit attributable to owners for the year ended 31 December 2025 is expected to be not less than HK$100 million, up from HK$69.2 million a year earlier. Management attributes the earnings growth primarily to a strengthened relationship and expanded business scale with a major customer in its imaging disposable products segment, which significantly boosted revenue, and to improved capacity utilisation and operating efficiency that delivered better economies of scale and an enhanced gross profit margin, although the figures remain subject to audit and investors are urged to exercise caution until final results are released by the end of March 2026.
The most recent analyst rating on (HK:1612) stock is a Buy with a HK$1.00 price target. To see the full list of analyst forecasts on Vincent Medical Holdings Limited stock, see the HK:1612 Stock Forecast page.
More about Vincent Medical Holdings Limited
Vincent Medical Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands, operating through subsidiaries in the medical products sector. The Group’s business includes imaging disposable products, serving major customers in this segment and focusing on scaling manufacturing capacity and improving operating efficiency to enhance margins.
Average Trading Volume: 532,336
Technical Sentiment Signal: Buy
Current Market Cap: HK$566.8M
For an in-depth examination of 1612 stock, go to TipRanks’ Overview page.